Optimi Health is trading 6.5% down at $4.32 today on profit-taking and broad biotech weakness, following several days of modest gains.
- There have been no new regulatory filings, press releases, or analyst actions to account for the downward movement.
- The decline appears to be driven by normal market volatility and a lack of fresh company-specific catalysts.